August 1, 2022
RegMed Investors’ (RMi) pre-open: will August be the month of my portfolio’s discontent?
July 29, 2022
RegMed Investors’ (RMi) pre-open: Finish the week and July with it
July 28, 2022
RegMed Investors’ (RMi) pre-open: Q2 GDP and sector earnings initiation
July 27, 2022
RegMed Investors’ (RMi) pre-open: the Fed speaks today at 2 p.m.
July 26, 2022
RegMed Investors’ (RMi) pre-open: a pivotal month ending week
July 25, 2022
RegMed Investors’ (RMi) pre-open: walking a tightrope of the oversold
July 22, 2022
RegMed Investors’ (RMi) pre-open: are risk parameters crashing the cell and gene therapy sector?
July 21, 2022
RegMed Investors’ (RMi) pre-open: the algos are coming, share pricing on a platter
July 20, 2022
RegMed Investors’ (RMi) pre-open: hang-in or hang-on; decrease risk going forward?
July 19, 2022
RegMed Investors’ (RMi) pre-open: shake, rattle and get rolled-over
July 18, 2022
RegMed Investors’ (RMi) pre-open: It's a fickle sector near resistance levels
July 15, 2022
RegMed Investors’ (RMi) pre-open: reversing some of the algo downslide curse
July 14, 2022
RegMed Investors’ (RMi) pre-open: ticks will be under pressure
July 13, 2022
RegMed Investors’ (RMi) pre-open: waiting for … value to stay-up or pick-up
July 12, 2022
RegMed Investors’ (RMi) pre-open: Never forget the road to value is a long and drawn-out journey, so slow as you go
July 11, 2022
RegMed Investors’ (RMi) pre-open: eenie, meenie, miney mo
July 8, 2022
RegMed Investors’ (RMi) pre-open: where and what are the catalysts to keep the sector up?
July 7, 2022
RegMed Investors’ (RMi) pre-open: what the market giveth, it also takes away
July 6, 2022
RegMed Investors’ (RMi) pre-open: I am a runner from some of these sector highs
July 5, 2022
RegMed Investors’ (RMi) pre-open: where is our share pricing dependence trapped?
July 1, 2022
RegMed Investors’ (RMi) pre-open: diving futures before long 3-day weekend ahead
June 30, 2022
RegMed Investors’ (RMi) pre-open: final trading session, ending June and Q2 couldn’t have come sooner
June 30, 2022
RegMed Investors’ (RMi) pre-open: final trading session, ending June and Q2 couldn’t have come sooner
June 29, 2022
RegMed Investors’ (RMi) pre-open: any attempt to kick-up share pricing is a good but, weak ask
June 28, 2022
RegMed Investors’ (RMi) pre-open: snap, crackle and pop
5 hours 19 min ago
RMi Closing Bell: Snow shoeing through Ai and cell and gene therapy sector blizzard
14 hours 26 min ago
RMi Pre-opening: Shovel-out the portfolio
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.